Gates Foundation Makes Start-Up Equity Investment – Are You Ready for Aerosol Vaccines?

By Luke Timmerman

Global health innovators have a rich new venture capitalist to turn to—the Bill & Melinda Gates Foundation.

Liquidia has attracted the interest in a technology for creating specific 3-D shaped particles that can be made to look like an invading virus does to the human immune system. Getting the proper shape is critically important, because it could coax the immune system to mount a defense against a particular invader. Even more importantly, Liquidia’s technique can be used to make these precise shapes, make them consistently, and do it in a scalable fashion, Holtzman says. Those are essential factors any company must figure out to make . . . .

Continue reading the article . . .

Related reading:

Solari Update _ Questions About Chemtrails
(18 May 10) Includes Quote of the Week:

The Foundation announced . . . a grant to support research [to] develop nanoparticles that penetrate the skin through hair follicles and burst upon contact with human sweat to release vaccines. ~ Press Release, Bill & Melinda Gates Foundation